| Financial Year |
March 31 2023 |
| Monetary Funds |
1,566,430,608.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,272,676,408.25 |
| Advances to Suppliers |
4,820,817.33 |
| Other Receivables |
11,437,205.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,649,856.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
274,054,494.06 |
| Total Current Assets |
4,146,069,389.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
966,634,878.96 |
| Investment Properties |
-- |
| Fixed Assetes |
10,268,928,939.52 |
| Under-construction Projects |
189,739,049.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,741,805.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,737,958.11 |
| Deferred Income Tax Assets |
36,528,832.37 |
| Other Non-Current Assets |
337,035,274.52 |
| Sub-Total of Non-Current Assets |
12,015,433,347.12 |
| Total Assets |
16,161,502,736.72 |
| Short-Term Loans |
164,208,095.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,333,847,103.43 |
| Accounts Received In Advance |
7,155.96 |
| Employee Compensation Payable |
8,356,943.59 |
| Taxes Payable |
65,852,262.24 |
| Interest Payable |
-- |
| Dividend Payable |
12,850,000.00 |
| Other payables |
103,401,253.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,802,905,453.84 |
| Other Current Liabilities |
4,230,560.96 |
| Sub-Total of Current Liabilities |
4,484,048,073.86 |
| Long-term Loans |
3,488,777,703.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
797,995,607.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
575,370.33 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,451,662,013.20 |
| Total Liabilities |
8,935,710,087.06 |
| Paid-In Capital(Or Share Stock) |
891,475,880.00 |
| Capital Surplus |
3,672,365,111.11 |
| Surplus Reserve |
122,847,749.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,561,165,475.34 |
| Minority Stockholder's Interest |
972,484,661.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,253,307,988.08 |
| Owner's Equity（Stockholder's Equity） |
7,225,792,649.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,161,502,736.72 |
